Posts by Alex Francis:
Industrial Good Stocks In Spotlight (CPST, FWLT, ITW)
Capstone Turbine Corporation (NASDAQ:CPST) surged 4.75% to $0.849. The 52-week range of the stock is $0.62-$1.45.
Capstone Turbine Corporation (Capstone) develops, manufactures, markets and services microturbine technology solutions for use in stationary distributed power generation applications, including cogeneration (combined heat and power (CHP), integrated combined heat and power (ICHP), and combined cooling, heat and power (CCHP)), resource recovery and secure power.
Foster Wheeler Ltd. (NASDAQ:FWLT) added 3.95% to $32.90. The 52-week range of the stock is $20.33-$35.01.
Foster Wheeler AG, formerly Foster Wheeler Limited, incorporated on November 18, 2008, operates through two business groups: Global Engineering and Construction Group (Global E&C Group)and Global Power Group. Global E&C Group, which operates worldwide, designs, engineers and constructs onshore and offshore upstream oil and gas processing facilities, natural gas liquefaction facilities and receiving terminals, gas-to-liquids facilities, oil refining, chemical and petrochemical, pharmaceutical and biotechnology facilities and related infrastructure, including power generation and distribution facilities, and gasification facilities.
Illinois Tool Works Inc. (NYSE:ITW) is down 0.61% to $50.25. The 52-week range of the stock is $40.33-$52.72. The stock is up more than 4% year-to-date.
Illinois Tool Works Inc. (ITW) is a multinational manufacturer of a diversified range of industrial products and equipment. The Company has approximately 840 operations in 57 countries, which are aggregated and organized into eight segments: Transportation, Industrial Packaging, Food Equipment, Power Systems and Electronics, Construction Products, Polymers and Fluids, Decorative Surfaces and All Other.
Drug Stocks Trading Actively (Arena Pharmaceuticals, Orexigen Therapeutics, JNJ)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is trading at $1.62, 14.89% higher. The 52-week range of the stock is $1.26-$8. The stock is down more than 54% year-to-date. Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four major therapeutic areas: cardiovascular, central [...]